Trial Profile
Efficacy of Bortezomib in kidney transplant paediatric patients with antibody mediated rejection.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 21 Dec 2015 New trial record